Literature DB >> 16797950

Investigation on physicochemical and biological differences of cefpodoxime proxetil enantiomers.

Vasu Kumar Kakumanu1, Vinod Arora, Arvind K Bansal.   

Abstract

Cefpodoxime proxetil (CP) is a prodrug of cefpodoxime acid (CA), and is supplied as racemic mixture of R- and S-enantiomers. CP has only 50% absolute bioavailability, and the reasons responsible for low bioavailability remain poorly understood. The present work ascertains physicochemical and biological properties of individual isomers of CP and explores their capacity to optimize delivery of CP. Both isomers showed similar pH stability behavior, but R-isomer was more susceptible to enzymatic metabolism compared to S-isomer, when incubated with enzymes collected from various segments of GIT. Based on the in vitro and in vivo results, use of S-isomer for development of a dosage form such as gastro-retentive dosage form can improve oral bioavailability of CP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16797950     DOI: 10.1016/j.ejpb.2006.05.001

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  2 in total

1.  Enhancement of bioavailability of cefpodoxime proxetil using different polymeric microparticles.

Authors:  Fahim Khan; Rajesh Katara; Suman Ramteke
Journal:  AAPS PharmSciTech       Date:  2010-09-04       Impact factor: 3.246

2.  Synthesis, pH-dependent, and plasma stability of meropenem prodrugs for potential use against drug-resistant tuberculosis.

Authors:  Aaron M Teitelbaum; Anja Meissner; Ryan A Harding; Christopher A Wong; Courtney C Aldrich; Rory P Remmel
Journal:  Bioorg Med Chem       Date:  2013-05-24       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.